TomegaVax Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

TomegaVax General Information

Description

Developer of an immunotherapy vaccine technology platform designed for treating chronic and recurring viral infections. The company's platform provides continuous low-level antigen presentation to maintain an active T-cell-mediated immune shield that brings previously intractable disease targets into the grasp of immune-based therapy, enabling patients to get vaccines and immunotherapies for chronic and recurring viral infections.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 4640 SouthWest Macadam Avenue
  • Suite 130A
  • Portland, OR 97239
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 4640 SouthWest Macadam Avenue
  • Suite 130A
  • Portland, OR 97239
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TomegaVax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 19-Oct-2020 Completed Out of Business
4. Grant 01-Jan-2018 Completed Generating Revenue
3. Grant 03-Mar-2017 Completed Generating Revenue
2. Later Stage VC (Series A) 01-Jan-2017 Completed Generating Revenue
1. Merger/Acquisition 01-Jan-2016 Completed Generating Revenue
To view TomegaVax’s complete valuation and funding history, request access »

TomegaVax FAQs

  • When was TomegaVax founded?

    TomegaVax was founded in 2011.

  • Where is TomegaVax headquartered?

    TomegaVax is headquartered in Portland, OR.

  • What industry is TomegaVax in?

    TomegaVax’s primary industry is Drug Discovery.

  • Is TomegaVax a private or public company?

    TomegaVax is a Private company.

  • What is TomegaVax’s current revenue?

    The current revenue for TomegaVax is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process